CadheRx Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

CadheRx Therapeutics General Information

Description

Developer of therapeutic antibodies designed to target and cure solid tumors. The company's antibodies are used in the treatment of solid tumors that are resistant to other treatments, particularly Cetuximab and Herceptin resistant epithelial cancers, enabling patients to remove solid tumors without surgery.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • San Diego, CA 92037
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CadheRx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 04-Apr-2017 0000 Completed Out of Business
1. Early Stage VC (Series A) 15-Jun-2015 0000 0000 Completed Startup
To view CadheRx Therapeutics’s complete valuation and funding history, request access »